Beacon Pointe Advisors, LLC Vyne Therapeutics Inc. Transaction History

Beacon Pointe Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.12 - $4.91 $120 - $4,910	-1,000 Reduced 1.33%	74,000 $11,000
Q1 2022 May 17, 2022	BUY	$0.5 - $1.15 $37,500 - $86,250	75,000 New	75,000 $49,000
Q4 2021 Feb 14, 2022	SELL	$0.91 - $1.5 $14,560 - $24,000	-16,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.39 - $3.47 $4,732 - $11,815	3,405 Added 27.03%	16,000 $22,000
Q2 2021 Aug 17, 2021	BUY	$3.24 - $6.92 $1,140 - $2,435	352 Added 2.88%	12,595 $44,000
Q1 2021 May 18, 2021	BUY	$6.34 - $12.68 $77,620 - $155,241	12,243 New	12,243 $83,000

36.5K

Ticker VYNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,005,600
Market Cap $170M
Description
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.